Literature DB >> 7365242

Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.

A P Gee, M D Boyle, T Borsos.   

Abstract

The intermediate product EAC1-7 released hemoglobin when incubated with high concentrations of GPC8 in the absence of C9. The reaction failed to reach an end point within 8 hr at 37 degrees C, and analysis of the kinetics indicated that it did not conform to the one-hit theory of immune hemolysis, and was not, therefore, the result of C9 contamination of the C8 preparation. The release of 86Rb from labeled EAC1-7 incubated at 30 degrees C with limiting C8 and excess C9 was paralleled, within 5 to 10 min, by release of hemoglobin. In the absence of C9 and with higher concentrations of C8, 86Rb was released rapidly, but hemoglobin release was delayed for several hours. Addition of excess C9 to concentrations of C8, which did not alone cause 86Rb release, resulted in substantial release of the isotope. These observations indicate that C9 acts by producing a distinct lesion in the cell membrane rather than by accelerating the release of hemoglobin from the C8-initiated 86Rb-releasing lesions. It is concluded that 86Rb release cannot be used as a reliable indicator of cell lysis and that C8- and C8/C9-mediated hemolysis are the result of mechanistically different processes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7365242

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription.

Authors:  Matthew Fosbrink; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Formation of ion-conducting channels by the membrane attack complex proteins of complement.

Authors:  J W Shiver; J R Dankert; A F Esser
Journal:  Biophys J       Date:  1991-10       Impact factor: 4.033

3.  Mesenchymal stem cells are injured by complement after their contact with serum.

Authors:  Yan Li; Feng Lin
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

4.  Complement induces a transient increase in membrane permeability in unlysed erythrocytes.

Authors:  J A Halperin; A Nicholson-Weller; C Brugnara; D C Tosteson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

5.  Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.

Authors:  Erika M Cook; Margaret A Lindorfer; Hilma van der Horst; Simone Oostindie; Frank J Beurskens; Janine Schuurman; Clive S Zent; Richard Burack; Paul W H I Parren; Ronald P Taylor
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

Review 6.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

Review 7.  Is the membrane attack complex of complement an enzyme?

Authors:  M D Boyle
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 8.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

9.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.